VRDN
$19.03-2.71%
Viridian Therapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.005%US Stock Market 0.003%Russell 3000 0.002%
Viridian Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Viridian Therapeutics Inc. total returns by year (2015–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $31.12 | $19.03 | 0.0% | -38.8% | |
| 2025 | $19.17 | $31.12 | 0.0% | +62.3% | |
| 2024 | $21.78 | $19.17 | 0.0% | -12.0% | |
| 2023 | $29.21 | $21.78 | 0.0% | -25.4% | |
| 2022 | $19.77 | $29.21 | 0.0% | +47.7% | |
| 2021 | $16.45 | $19.77 | 0.0% | +20.2% | |
| 2020 | $7.20 | $16.45 | 0.0% | +128.5% | |
| 2019 | $45.45 | $7.20 | 0.0% | -84.2% | |
| 2018 | $156.45 | $45.45 | 0.0% | -70.9% | |
| 2017 | $75.15 | $156.45 | 0.0% | +108.2% | |
| 2016 | $168.30 | $75.15 | 0.0% | -55.3% | |
| 2015 | $571.50 | $168.30 | 0.0% | -70.6% |
- Annualized
- -30.2%
- 2015–2026
- Average year
- +4.4%
- 11 full years
- Best year
- +128.5%
- 2020
- Worst year
- -84.2%
- 2019
- Positive years
- 5/11
- 45% up
Annualized (CAGR)
-30.2%
2015–2026
Average year
+4.4%
11 full years
Best year
+128.5%
2020
Worst year
-84.2%
2019
Positive years
5/11
45% up
Total return by period#
Annual
-100%-50%0%50%100%
2015-71%'15
2016-55%'16
2017+108%'17
2018-71%'18
2019-84%'19
2020+128%'20
2021+20%'21
2022+48%'22
2023-25%'23
2024-12%'24
2025+62%'25
2026-39%'26
Methodology#
Total returns, dividends reinvested, measured on VRDN. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Viridian Therapeutics Inc.'s average annual return?
- Since 2015, Viridian Therapeutics Inc. (VRDN) has returned about -30.2% a year (the compound annual growth rate) and an average calendar-year return of 4.4%.
- What were Viridian Therapeutics Inc.'s best and worst years?
- Over 2015–2026, the best year was 2020 (+128.5%) and the worst was 2019 (-84.2%).
- How often is Viridian Therapeutics Inc. up in a year?
- 5 of the 11 full years since 2015 were positive — about 45% of the time.
More on Viridian Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100